The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies

We have synthesized a novel derivative of indomethacin, phospho-tyrosol-indomethacin (PTI; MPI-621), and evaluated its anticancer efficacy in vitro and in vivo. PTI inhibited the growth of human colon, breast and lung cancer cell lines 6–30-fold more potently than indomethacin. In vivo, in contrast...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhou, Dingying, Papayannis, Ioannis, Mackenzie, Gerardo G., Alston, Ninche, Ouyang, Nengtai, Huang, Liqun, Nie, Ting, Wong, Chi C., Rigas, Basil
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Original Manuscript
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616666/
https://ncbi.nlm.nih.gov/pubmed/23338686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgs394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars